NL930030I2 - Meerfasisch 'opeenvolgend' preparaat van het combinatie-type voor orale anticonceptie en methode voor orale anticonceptie. - Google Patents

Meerfasisch 'opeenvolgend' preparaat van het combinatie-type voor orale anticonceptie en methode voor orale anticonceptie.

Info

Publication number
NL930030I2
NL930030I2 NL930030C NL930030C NL930030I2 NL 930030 I2 NL930030 I2 NL 930030I2 NL 930030 C NL930030 C NL 930030C NL 930030 C NL930030 C NL 930030C NL 930030 I2 NL930030 I2 NL 930030I2
Authority
NL
Netherlands
Prior art keywords
oral contraception
phase
combination
dose
multiphase
Prior art date
Application number
NL930030C
Other languages
English (en)
Other versions
NL930030I1 (nl
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19835016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL930030(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NL930030I1 publication Critical patent/NL930030I1/nl
Publication of NL930030I2 publication Critical patent/NL930030I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Details Of Television Scanning (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NL930030C 1980-03-18 1993-04-28 Meerfasisch 'opeenvolgend' preparaat van het combinatie-type voor orale anticonceptie en methode voor orale anticonceptie. NL930030I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8001593A NL8001593A (nl) 1980-03-18 1980-03-18 Meerfasisch combinatiepreparaat voor orale anticonceptie.

Publications (2)

Publication Number Publication Date
NL930030I1 NL930030I1 (nl) 1993-07-01
NL930030I2 true NL930030I2 (nl) 1994-02-16

Family

ID=19835016

Family Applications (3)

Application Number Title Priority Date Filing Date
NL8001593A NL8001593A (nl) 1980-03-18 1980-03-18 Meerfasisch combinatiepreparaat voor orale anticonceptie.
NL930030C NL930030I2 (nl) 1980-03-18 1993-04-28 Meerfasisch 'opeenvolgend' preparaat van het combinatie-type voor orale anticonceptie en methode voor orale anticonceptie.
NL950017C NL950017I2 (nl) 1980-03-18 1995-08-29 Meerfasisch "opeenvolgend" preparaat van het combinatie-type voor orale anticonceptie en methode vo or orale anticonceptie.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL8001593A NL8001593A (nl) 1980-03-18 1980-03-18 Meerfasisch combinatiepreparaat voor orale anticonceptie.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL950017C NL950017I2 (nl) 1980-03-18 1995-08-29 Meerfasisch "opeenvolgend" preparaat van het combinatie-type voor orale anticonceptie en methode vo or orale anticonceptie.

Country Status (14)

Country Link
US (1) US4378356A (nl)
EP (1) EP0036229B1 (nl)
JP (1) JPS56140914A (nl)
AT (1) ATE11371T1 (nl)
AU (1) AU546010B2 (nl)
CA (1) CA1158981A (nl)
DE (2) DE10075014I1 (nl)
DK (1) DK162474C (nl)
FI (1) FI72649C (nl)
GR (1) GR74473B (nl)
IE (1) IE50988B1 (nl)
MX (1) MX9203812A (nl)
NL (3) NL8001593A (nl)
ZA (1) ZA811490B (nl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530839A (en) * 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4962098A (en) * 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
AU581486B2 (en) * 1985-12-30 1989-02-23 Warner-Lambert Company Graduated estrogen contraceptive
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
ES2024010B3 (es) * 1987-07-06 1992-02-16 Akzo Nv Unidad de dosis farmaceutica.
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
DE4104385C1 (nl) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
WO1997041870A1 (en) * 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
HUP0900698A2 (en) 2009-11-06 2011-06-28 Richter Gedeon Nyrt Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39264A (en) * 1863-07-14 Improvement in hay-loaders
US3409721A (en) * 1967-09-15 1968-11-05 Neomed Lab Inc Oral dosage system effective to control the reproduction cycle
DE2265435C2 (de) * 1972-04-14 1980-01-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verwendung von Hormonen zur Kontrazeption
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents

Also Published As

Publication number Publication date
DE10075014I1 (de) 2000-09-07
MX9203812A (es) 1992-07-01
NL950017I2 (nl) 1996-12-02
US4378356A (en) 1983-03-29
NL930030I1 (nl) 1993-07-01
AU546010B2 (en) 1985-08-08
DE3168420D1 (en) 1985-03-07
GR74473B (nl) 1984-06-28
FI72649C (fi) 1987-07-10
NL950017I1 (nl) 1995-11-01
FI810805L (fi) 1981-09-19
IE50988B1 (en) 1986-09-03
EP0036229B1 (en) 1985-01-23
CA1158981A (en) 1983-12-20
DK118881A (da) 1981-09-19
EP0036229A1 (en) 1981-09-23
NL8001593A (nl) 1981-10-16
JPH0153252B2 (nl) 1989-11-13
ATE11371T1 (de) 1985-02-15
DK162474B (da) 1991-11-04
DK162474C (da) 1992-04-06
AU6821081A (en) 1981-09-24
ZA811490B (en) 1982-03-31
FI72649B (fi) 1987-03-31
IE810468L (en) 1981-09-18
JPS56140914A (en) 1981-11-04

Similar Documents

Publication Publication Date Title
NL930030I2 (nl) Meerfasisch 'opeenvolgend' preparaat van het combinatie-type voor orale anticonceptie en methode voor orale anticonceptie.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
JPS5312844A (en) Nn44halogenobenzyllnnmethyl*or nonsubstitutedd*cycloalkylln**phenylurea or thiourea compounds* their preparation and fungicides containing the same as active constituents
NO845194L (no) Flertrinnskombinasjonspreparat og anvendelse av dette som oralt antikonsepsjonsmiddel
IL57796A0 (en) Pharmaceutical compositions having retarded release of the active substance
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
DE3266360D1 (en) Medicines containing as active ingredients compounds of the arylbenzenesulfonamide-type, and processes for their preparation
DE3267295D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
IT8321720A0 (it) Composizioni di profumo a cessione protratta e un procedimento per laloro preparazione.
DE2962567D1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
NL7608333A (nl) Werkwijze voor de bereiding van reukstoffen, alsmede werkwijze voor de bereiding van reuk- stofcomposities.
SE7909106L (sv) Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika
ZA83772B (en) Substituted thienobenzodiazepinones,processes for the preparations thereof and pharmaceutical compositions containing these compounds
IL51373A (en) Pharmaceutical compositions containing halocinnamides,certain such compounds and their preparation
DE3264304D1 (en) Use of 2-hydroxy-3,4,4-trimethyl-cyclopent-2-ene-1-one as odorant ingredient
DE3360323D1 (en) Trimethylbicyclo(4.3.0)non-1-ene derivatives, their preparation and use as perfumes, and the perfumed compositions containing them
DE2861571D1 (en) Amidines, their preparation and pharmaceutical compositions containing them.
IT8319401A0 (it) Peptide e agente ormonale contenente lo stesso come ingrediente attivo.
IL72084A0 (en) Dihydrofuran derivatives,fragrance compositions containing the same and processes for the preparation thereof
IL58729A0 (en) Hydroxyalkyl pyrid-2-yldithiocarbamates processes for their preparation and pharmaceutical compositions containing the same
DE3465474D1 (en) Oxaspirododecane compounds, their preparation and their use as perfumes, and perfume compositions containing them
NO163187C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 1,6-naftyridinderivater.
NO803022L (no) Anordning for separasjon av faste bestanddeler.
HK33385A (en) 3-hydroxy-1,4-benzodiazepine-2-ones,process for the preparation thereof and compositions containing them
NO168531C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.